Stuart Kloda, MD – Alcohol Addiction – Naltrexone – Topamax – Baclofen – Neurontin – New York City
Stuart Kloda, MD – Alcohol Addiction – Naltrexone – Topamax – Baclofen – Neurontin – New York City – www.stuartklodamd.com Call Dr. Kloda directly at (646) 713-6578 Concierge addiction treatment for New York City and New Jersey. Dr. Kloda completed a rigorous two-year Addiction Medicine fellowship at the Addiction Institute of New York, a Columbia University affiliate in Manhattan located at St. Luke’s & Roosevelt hospitals. His experience includes serving as the medical director for the inpatient drug and alcohol detoxification and rehabilitation unit at Roosevelt Hospital. Dr. Kloda cared for many patients with co-occurring psychiatric and medical illnesses. Dr. Kloda now provides discreet, confidential, one-on-one treatment in his private office at Columbus Circle. His hours are flexible, including early morning, evening, and weekend hours. In addition, Dr. Kloda is always available to his patients on his cell phone. His treatment philosophy is one of flexibility and choice. Dr. Kloda’s approach is that there are different ways to attain recovery and to maintain sobriety. He focuses on doing “what works”, and on customizing treatment to each individual patient’s unique needs and circumstances. vivitrol nyc vivitrol new york city naltrexone nyc naltrexone new york city topamax alcohol nyc baclofen alcohol new york city neurontin alcohol nyc alcoholic new york city alcoholic nyc alcoholics anonymous new york city AA meetings nyc 12-step meetings new york city suboxone doctor new york city suboxone doctors taking patients nyc addiction medicine nyc addiction counseling …
5 Signs Drinking Is Making Your Holiday Less Merry
Filed under: drug treatment programs in maryland
David Sack, M.D., is board certified in addiction psychiatry and addiction medicine. Dr. Sack served as a senior clinical scientist at the National Institute of Mental Health (NIMH) … affective disorders, seasonal and circadian rhythms, and …
Read more on PsychCentral.com (blog)
FDA Approves First Drug-Eluting Stent in U.S. for Peripheral Arterial Disease
Filed under: drug treatment programs in maryland
“This approval marks the start of Cook's program to bring the benefits of drug elution to U.S. physicians treating the peripheral arteries,” says Rob Lyles, vice president and global leader of Cook Medical's Peripheral Intervention division. … “After …
Read more on Today’s Medical Developments